argus

Cohance Lifesciences Limited

NSE: COHANCEINE03QK01018₹17,559 Cr

Timeline

Time (IST)TypeMEventSrc
28 Oct, 06:06 pm—…Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
28 Oct, 05:49 pm—…Cohance Lifesciences Limited has informed the Exchange regarding Change in Director(s) of the company.nse
26 Oct, 06:04 pm—…Cohance Lifesciences Ltd - 543064 - General Updatebse
26 Oct, 06:04 pm—…Cohance Lifesciences Limited has informed the Exchange about General Updatesnse
27 Sept, 11:16 pm—…Cohance Lifesciences Ltd - 543064 - Board Meeting Intimation for Considering And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company, For The Quarter And Half Year Ending September 30, 2025.bse
22 Sept, 01:42 pm—…Cohance Lifesciences Ltd - 543064 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
22 Sept, 08:44 am—…Cohance Lifesciences Ltd - 543064 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
19 Sept, 10:09 am—…Cohance Lifesciences Ltd - 543064 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
18 Sept, 11:37 pm—…Cohance Lifesciences Limited has informed the Exchange about clarification on reported news in electronic medianse
18 Sept, 07:26 pm—…Cohance Lifesciences Limited has informed the Exchange about disclosure under SEBI PIT Regulationsnse
11 Sept, 06:09 pm—…Cohance Lifesciences Limited has informed the Exchange about Completion of USFDA Inspectionnse